AbbVie to Invest $380M in North Chicago API Facilities Expansion
AbbVie will invest $380 million in its North Chicago active pharmaceutical ingredient facilities, upgrading capacity and technology. The expansion is intended to bolster production of key therapies and strengthen manufacturing resilience.
1. Investment Overview
AbbVie plans to invest $380 million in its North Chicago API facilities to upgrade production capacity, implement advanced process controls and enhance technology platforms. This project aims to secure a reliable supply of active pharmaceutical ingredients for its core therapies and support future pipeline manufacturing requirements.
Related News
MKL
Markel Appoints Danny O’Donoghue, 15-Year Fine Art & Specie Underwriter, to Lead London Unit
MKL•
AAPL
Taiwan’s $62.5B Surplus Fuels Apple AI Capex with 111% Q1 Surge
AAPL•
GOOG
Ackman Cuts Alphabet Stake 95% as Nvidia Forecast Raises Google Cloud Competition
GOOG•
Z
Zillow Mortgage Rates Climb: 30-Year Fixed Hits 6.55%, 5/1 ARM at 6.80%
Z•
ING
ING-backed euro stablecoin consortium grows to 37 banks, eyes H2 launch
ING•
Sources
F